I recieved the labs from my first infusion 2 weeks ago. The viral load came back fairly close to the number it was prior to infusion. The Cd4 had not changed much either. The Doctor, who works for Virxsys, the company that developed VRX496, thought that the Viral load would spike real high at the intitial dose. Then, with each sequential dose, it would spike lower and lower.
The base line labs prior to joining the trial were as follows:
August 8th – VL = 11, 900 CD4=455 Drawn By Clinic under supervision of my physician prior to the trial.
Because of protocol, Virxsys has requested that specific objective lab data drawn during their study not be disclosed.